Merck snags Chinese obesity drug in nearly US$2 billion deal
MERCK snagged a potential drug in the burgeoning market for obesity medications in a deal worth as much as US$2 ...
Tag: obesity
Lilly to boost obesity drug supply with US$3 billion expansion
ELI Lilly is spending another US$3 billion to build out its US manufacturing footprint as it ramps up production of ...
Novo Nordisk launches obesity drug Wegovy in China
The price for a month’s supply of the starter dose of Wegovy will be 1,400 yuanNovo Nordisk said on Monday ...
Obesity drugmaker Novo Nordisk posts strong profit
Danish pharmaceutical giant Novo Nordisk, maker of the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy, posted on Wednesday (Nov ...
Novo Nordisk confident of amycretin obesity drug launch this decade
NOVO Nordisk’s head of development on Friday (Mar 8) told Reuters he was very comfortable the drugmaker would be able ...
A New Weight-Loss Drug Could Be a Complete Game Changer | Entrepreneur
In recent months, there has been a swelling interest in using diabetes drugs to treat weight loss.Drugs with brand names ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.